| Nr. | Form | Titel | KP | Hör. | ||||
|---|---|---|---|---|---|---|---|---|
| 2025005FS 2026 | Vorlesung | Regulatory Aspects for Approval of Therapeutics |
Lothar Aicher Stéphanie Boudon Reginald Edward FitzGerald Martin F. Wilks |
1 |
wöchentlich 4Donnerstag, 13.15-15.00 Pharmazentrum, Hörsaal 2 |
0 | ||
| 2025004HS 2025 | Hauptvorlesung | Allgemeine Toxikologie |
Jörg Huwyler Stephan Krähenbühl Alex Odermatt Martin F. Wilks |
1 |
wöchentlich 4Donnerstag, 08.15-10.00 Biozentrum, Hörsaal U1.101 |
|||
| 2025004HS 2025 | Vorlesung | Chemical Risk Assessment |
Lothar Aicher Reginald Edward FitzGerald Martin F. Wilks |
1 |
wöchentlich 2Dienstag, 08.15-10.00 Biozentrum, Seminarraum U1.191 |
0 | ||
| 2024005FS 2025 | Vorlesung | Regulatory Aspects for Approval of Therapeutics |
Lothar Aicher Stéphanie Boudon Reginald Edward FitzGerald Martin F. Wilks |
1 |
wöchentlich 4Donnerstag, 13.15-15.00 Pharmazentrum, Hörsaal 2 |
0 | ||
| 2024004HS 2024 | Hauptvorlesung | Allgemeine Toxikologie |
Jörg Huwyler Stephan Krähenbühl Alex Odermatt Martin F. Wilks |
1 |
wöchentlich 4Donnerstag, 08.15-10.00 Biozentrum, Hörsaal U1.101 |
|||
| 2024004HS 2024 | Vorlesung | Chemical Risk Assessment |
Lothar Aicher Reginald Edward FitzGerald Martin F. Wilks |
1 |
wöchentlich 2Dienstag, 08.15-10.00 Biozentrum, Seminarraum U1.191 |
|||
| 2023005FS 2024 | Vorlesung | Regulatory Aspects for Approval of Therapeutics |
Lothar Aicher Stéphanie Boudon Reginald Edward FitzGerald Martin F. Wilks |
1 |
wöchentlich 4Donnerstag, 13.15-15.00 Pharmazentrum, Hörsaal 2 |
|||
| 2023004HS 2023 | Hauptvorlesung | Allgemeine Toxikologie |
Jörg Huwyler Stephan Krähenbühl Alex Odermatt Martin F. Wilks |
1 |
wöchentlich 4Donnerstag, 08.15-10.00 Biozentrum, Hörsaal U1.101 |
|||
| 2023004HS 2023 | Vorlesung | Chemical Risk Assessment |
Lothar Aicher Reginald Edward FitzGerald Martin F. Wilks |
1 |
wöchentlich 2Dienstag, 08.15-10.00 Biozentrum, Seminarraum U1.191 |
|||
| 2022005FS 2023 | Vorlesung | Chemical Risk Assessment |
Lothar Aicher Reginald Edward FitzGerald Martin F. Wilks |
1 |
wöchentlich 3Mittwoch, 13.15-15.00 Pharmazentrum, Hörsaal 2 |
|||
| 2022005FS 2023 | Vorlesung | Regulatory Aspects for Approval of Therapeutics |
Lothar Aicher Stéphanie Boudon Reginald Edward FitzGerald Martin F. Wilks |
1 |
wöchentlich 4Donnerstag, 13.15-15.00 Pharmazentrum, Hörsaal 2 |
|||
| 2022004HS 2022 | Hauptvorlesung | Allgemeine Toxikologie |
Jörg Huwyler Stephan Krähenbühl Alex Odermatt Martin F. Wilks |
1 |
wöchentlich 4Donnerstag, 08.15-10.00 Biozentrum, Hörsaal U1.101 |
|||
| 2021005FS 2022 | Vorlesung | Chemical Risk Assessment |
Lothar Aicher Reginald Edward FitzGerald Martin F. Wilks |
1 |
wöchentlich 3Mittwoch, 13.15-15.00 Biozentrum, Seminarraum U1.197 |
|||
| 2021005FS 2022 | Vorlesung | Regulatory Aspects for Approval of Therapeutics |
Lothar Aicher Reginald Edward FitzGerald Martin F. Wilks |
1 |
wöchentlich 4Donnerstag, 13.15-15.00 Pharmazentrum, Hörsaal 2 |
|||
| 2021004HS 2021 | Hauptvorlesung | Allgemeine Toxikologie |
Jörg Huwyler Stephan Krähenbühl Alex Odermatt Martin F. Wilks |
1 |
wöchentlich 4Donnerstag, 08.15-10.00 - Online Präsenz - |
|||
| 2020005FS 2021 | Vorlesung | Chemical Risk Assessment |
Lothar Aicher Reginald Edward FitzGerald Martin F. Wilks |
1 |
wöchentlich 3Mittwoch, 13.15-15.00 - Online Präsenz - |
|||
| 2020005FS 2021 | Vorlesung | Regulatory Aspects for Approval of Therapeutics |
Lothar Aicher Reginald Edward FitzGerald Martin F. Wilks |
1 |
wöchentlich 4Donnerstag, 13.15-15.00 - Online Präsenz - |
|||
| 2019005FS 2020 | Vorlesung | Chemical Risk Assessment |
Lothar Aicher Reginald Edward FitzGerald Martin F. Wilks |
1 | ||||
| 2019005FS 2020 | Vorlesung | Regulatory Aspects for Approval of Therapeutics |
Martin F. Wilks |
1 | ||||
| 2018005FS 2019 | Vorlesung | Chemical Risk Assessment |
Lothar Aicher Reginald Edward FitzGerald Martin F. Wilks |
1 | ||||
| 2018005FS 2019 | Vorlesung | Regulatory Aspects for Approval of Therapeutics |
Martin F. Wilks |
1 | ||||
| 2017005FS 2018 | Vorlesung | Chemical Risk Assessment |
Lothar Aicher Reginald Edward FitzGerald Martin F. Wilks |
1 | ||||
| 2017005FS 2018 | Vorlesung | Regulatory Aspects for Approval of Therapeutics |
Martin F. Wilks |
1 | ||||
| 2016005FS 2017 | Vorlesung | Chemical Risk Assessment |
Lothar Aicher Reginald Edward FitzGerald Martin F. Wilks |
1 | ||||
| 2016005FS 2017 | Vorlesung | Regulatory Aspects for Approval of Therapeutics |
Martin F. Wilks |
1 | ||||
| 2015005FS 2016 | Vorlesung | Regulatory Toxicology, Risk Assessment |
Martin F. Wilks |
2 | ||||
| 2015004HS 2015 | Vorlesung | Essentials of Toxicology I |
Stephan Krähenbühl Luigi M. Terracciano Martin F. Wilks |
2 | ||||
| 2014005FS 2015 | Vorlesung | Regulatory Toxicology, Risk Assessment |
Martin F. Wilks |
2 | ||||
| 2014004HS 2014 | Vorlesung | Essentials in Toxicology I |
Stephan Krähenbühl Luigi M. Terracciano Martin F. Wilks |
2 | ||||
| 2013005FS 2014 | Vorlesung | Regulatory Toxicology, Risk Assessment |
Martin F. Wilks |
2 | ||||
| 2013004HS 2013 | Vorlesung | Essentials in Toxicology I |
Stephan Krähenbühl Luigi M. Terracciano Martin F. Wilks |
2 | ||||
| 2012005FS 2013 | Vorlesung | Regulatory Toxicology, Risk Assessment |
Martin F. Wilks |
2 | ||||
| 2011005FS 2012 | Vorlesung | Regulatory Toxicology, Risk Assessment |
Martin F. Wilks |
2 |